AK Medical Holdings Limited submitted its monthly return for the period ended 28 February 2026. The authorized share capital remained at 2.00 billion ordinary shares, each at HKD 0.01 par value, totaling HKD 20.00 million. The issued share capital stayed at 1.12 billion shares, and the public float requirement of 25.00% was confirmed as satisfied.

Share options under the company’s schemes showed minor lapses, resulting in adjusted balances. No new shares were issued or transferred from treasury under these options. During 6 to 16 February 2026, 2.87 million shares were repurchased for cancellation but had not been canceled as of 28 February 2026.